Macter International Limited (PSX:MACTER)

Market Cap	16.41B
Revenue (ttm)	10.36B
Net Income (ttm)	776.43M
Shares Out	45.81M
EPS (ttm)	16.95
PE Ratio	21.13
Forward PE	n/a
Dividend	3.80 (1.06%)
Ex-Dividend Date	Oct 16, 2025

Volume	77,526
Average Volume	120,601
Open	364.82
Previous Close	364.82
Day's Range	356.00 - 369.00
52-Week Range	114.04 - 621.82
Beta	0.39
RSI	36.32
Earnings Date	Nov 21, 2025

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1992
• Employees: 1,282
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: MACTER

Financial Performance

In 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.